SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001437749-23-024449
Filing Date
2023-08-22
Accepted
2023-08-22 16:52:06
Documents
9
Period of Report
2023-08-22

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14C arch20230822_pre14c.htm PRE 14C 605417
2 a01.jpg GRAPHIC 469288
3 a02.jpg GRAPHIC 354164
4 arch20230822_pre14cimg001.jpg GRAPHIC 4781
5 arch20230822_pre14cimg002.jpg GRAPHIC 4781
6 b01.jpg GRAPHIC 469288
7 b02.jpg GRAPHIC 352959
8 c01.jpg GRAPHIC 469640
9 c02.jpg GRAPHIC 357157
  Complete submission text file 0001437749-23-024449.txt   4025867
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: PRE 14C | Act: 34 | File No.: 000-54986 | Film No.: 231194108
SIC: 3841 Surgical & Medical Instruments & Apparatus